RECURSION PHARMACEUTICALS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.655 USD | +0.76% |
|
-1.93% | -12.58% |
| Apr. 18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
| Apr. 16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 9.090 | 15.52 | 15.47 |
| Spread/Res. | -5.17% | -44.46% | -44.28% |
| Spread/Supp. | +17.28% | +64.82% | +63.26% |
| Support | 7.350 | 5.230 | 5.280 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- RXRX Stock
- Charts Recursion Pharmaceuticals, Inc.